Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 4 of 4 for “"Spravato"”.
-
Modulating Ketamine’s Locomotor Activating and Reinforcing Effects Through Drug Combinations
… (S)-ketamine was approved as a nasal spray (Spravato®) for patients with MDD and treatment-resistant depression in conjunction with their previously prescribed MAAs. However, ketamine has limitations of its own, such as producing sedation and dissociative effects as well as having known abuse …
-
Effects of (R,S)-ketamine and (2R,6R)-hydroxynorketamine: a preclinical study
… FDA approved (S) ketamine (esketamine, Ketanest, Spravato) for treatment-resistant depression in March 2019. Excitement for a better treatment, however, is lessened by reports indicating that some patients may experience severe side effects like reduced cognitive functioning a day or more after …
-
Intranasales Esketamin zur Behandlung der akuten Depression
Fragestellung: Reduziert intranasales Esketamin, ergänzend zur Regelbehandlung, schwere depressive Symptome einhergehend mit akuter Suizidalität innerhalb von 24 Stunden und hält ein etwaiger Effekt mittelfristig an? Methodik: Die hier analysierten Daten wurden im Rahmen einer doppelblinden, …
-
Ketamine: a feasible replacement for current major depressive disorder therapies
Major depressive disorder (MDD) is among the most common mental health problems in the U.S. and the world. A significant portion of patients with MDD do not respond to current antidepressant medications and are considered treatment-resistant. Current antidepressant therapies have a late onset of …